Hepatitis B infection increases the risk of non-Hodgkin lymphoma: A meta-analysis of observational studies

Leukemia Research

Volumn 37, Issue 9, 2013, Pages 1107-1115

  Dalia, Samir ^a   Chavez, Julio ^a   Castillo, Jorge J ^b   Sokol, Lubomir ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Diffuse large b cell lymphoma; Follicular lymphoma; Hepatitis B; NHL; Non Hodgkin lymphoma; T cell lymphoma

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ANTIGEN DETECTION; ARTICLE; CANCER RISK; CARCINOGENESIS; CHRONIC LYMPHATIC LEUKEMIA; DISEASE ASSOCIATION; FOLLICULAR LYMPHOMA; HEPATITIS B; HUMAN; LARGE CELL LYMPHOMA; LYMPHOCYTOMA; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; T CELL LYMPHOMA;

DIFFUSE LARGE B-CELL LYMPHOMA; FOLLICULAR LYMPHOMA; HEPATITIS B; NHL; NON-HODGKIN LYMPHOMA; T-CELL LYMPHOMA;

CASE-CONTROL STUDIES; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LYMPHOMA, NON-HODGKIN; PROGNOSIS;

EID: 84880944220     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2013.06.007     Document Type: Article

References (51)

1. SEER. SEER Cancer statistics. 2012.
2. Bassig B.A., Lan Q., Rothman N., Zhang Y., Zheng T. Current understanding of lifestyle and environmental factors and risk of non-hodgkin lymphoma: an epidemiological update. J Cancer Epidemiol 2012, 2012:978930.
3. Engels E.A. Infectious agents as causes of non-Hodgkin lymphoma. Cancer Epidemiol Biomark Prev 2007, 16:401-404.
4. Matsuo K., Kusano A., Sugumar A., Nakamura S., Tajima K., Mueller N.E. Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: a meta-analysis of epidemiological studies. Cancer Sci 2004, 95:745-752.
5. Dal Maso L., Franceschi S. Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomark Prev 2006, 15:2078-2085.
6. Lim S.T., Fei G., Quek R., Lim L.C., Lee L.H., Yap S.P., et al. The relationship of hepatitis B virus infection and non-Hodgkin's lymphoma and its impact on clinical characteristics and prognosis. Eur J Haematol 2007, 79:132-137.
7. Organization WH. Hepatitis B vaccines. Weekly epidemiological record 2009, 15. World Health Organization, http://www.who.int/wor.
8. Goldstein S.T., Zhou F., Hadler S.C., Bell B.P., Mast E.E., Margolis H.S. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005, 34:1329-1339.
9. Nath A., Agarwal R., Malhotra P., Varma S. Prevalence of hepatitis B virus infection in non-Hodgkin lymphoma: a systematic review and meta-analysis. Intern Med J 2010, 40:633-641.
10. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012.
11. Institute OHR. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.
12. Zhang J., Yu K.F. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 1998, 280:1690-1691.
13. Teshale E.H. Hepatits B. Chapter 3: Infectious Diseases Related to Travel 2012, Centers for Disease Control and Prevention.
14. Okan V., Yilmaz M., Bayram A., Kis C., Cifci S., Buyukhatipoglu H., et al. Prevalence of hepatitis B and C viruses in patients with lymphoproliferative disorders. Int J Hematol 2008, 88:403-408.
15. Kang J., Cho J.H., Suh C.W., Lee D.H., Oh H.B., Sohn Y.H., et al. High prevalence of hepatitis B and hepatitis C virus infections in Korean patients with hematopoietic malignancies. Ann Hematol 2011, 90:159-164.
16. Kim J.H., Bang Y.J., Park B.J., Yoo T., Kim C.W., Kim T.Y., et al. Hepatitis B virus infection and B-cell non-Hodgkin's lymphoma in a hepatitis B endemic area: a case-control study. Jpn J Cancer Res 2002, 93:471-477.
17. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558.
18. Duval S., Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000, 56:455-463.
19. Amin J., Dore G.J., O'Connell D.L., Bartlett M., Tracey E., Kaldor J.M., et al. Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study. J Hepatol 2006, 45:197-203.
20. Proby C., Minello A., Quantin C., Jooste V., Binquet C., Hagi M., et al. Chronic viral hepatitis and risk of lymphoid malignancies: a retrospective twelve-year population-based cohort study in Cote d'Or, France. Dig Liver Dis 2012, 44:160-165.
21. Fwu C.W., Chien Y.C., You S.L., Nelson K.E., Kirk G.D., Kuo H.S., et al. Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan. Hepatology 2011, 53:1217-1225.
22. Engels E.A., Cho E.R., Jee S.H. Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study. Lancet Oncol 2010, 11:827-834.
23. Ulcickas Yood M., Quesenberry C.P., Guo D., Caldwell C., Wells K., Shan J., et al. Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection. Hepatology 2007, 46:107-112.
24. Anderson L.A., Pfeiffer R., Warren J.L., Landgren O., Gadalla S., Berndt S.I., et al. Hematopoietic malignancies associated with viral and alcoholic hepatitis. Cancer Epidemiol Biomark Prev 2008, 17:3069-3075.
25. Chen M.H., Hsiao L.T., Chiou T.J., Liu J.H., Gau J.P., Teng H.W., et al. High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin's lymphoma. Ann Hematol 2008, 87:475-480.
26. Cucuianu A., Patiu M., Duma M., Basarab C., Soritau O., Bojan A., et al. Hepatitis B and C virus infection in Romanian non-Hodgkin's lymphoma patients. Br J Haematol 1999, 107:353-356.
27. El-Sayed G.M., Mohamed W.S., Nouh M.A., Moneer M.M., El-Mahallawy H.A. Viral genomes and antigen detection of hepatitis B and C viruses in involved lymph nodes of Egyptian non-Hodgkin's lymphoma patients. Egypt J Immunol 2006, 13:105-114.
28. Franceschi S., Lise M., Trepo C., Berthillon P., Chuang S.C., Nieters A., et al. Infection with hepatitis B and C viruses and risk of lymphoid malignancies in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Epidemiol Biomark Prev 2011, 20:208-214.
29. Iwata H., Matsuo K., Takeuchi K., Kishi Y., Murashige N., Kami M. High incidences of malignant lymphoma in patients infected with hepatitis B or hepatitis C virus. Haematologica 2004, 89:368-370.
30. Kuniyoshi M., Nakamuta M., Sakai H., Enjoji M., Kinukawa N., Kotoh K., et al. Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma. J Gastroenterol Hepatol 2001, 16:215-219.
31. Marcucci F., Mele A., Spada E., Candido A., Bianco E., Pulsoni A., et al. High prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphoma. Haematologica 2006, 91:554-557.
32. Medhi S.R.A.A., Rahman A. Hepatitis B&C virus infection in cases of non-Hodgkin's lymphoma in Saudi Arabia. Turk J Hematol 2006, 23:4.
33. Park S.C., Jeong S.H., Kim J., Han C.J., Kim Y.C., Choi K.S., et al. High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin's lymphoma in Korea. J Med Virol 2008, 80:960-966.
34. Sonmez M., Bektas O., Yilmaz M., Durmus A., Akdogan E., Topbas M., et al. The relation of lymphoma and hepatitis B virus/hepatitis C virus infections in the region of East Black Sea, Turkey. Tumori 2007, 93:536-539.
35. Wang F., Xu R.H., Han B., Shi Y.X., Luo H.Y., Jiang W.Q., et al. High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers. Cancer 2007, 109:1360-1364.
36. Becker N., Schnitzler P., Boffetta P., Brennan P., Foretova L., Maynadie M., et al. Hepatitis B virus infection and risk of lymphoma: results of a serological analysis within the European case-control study Epilymph. J Cancer Res Clin Oncol 2012, 138:1993-2001.
37. Castillo J.J., Dalia S., Pascual S.K. Association between red blood cell transfusions and development of non-Hodgkin lymphoma: a meta-analysis of observational studies. Blood 2010, 116:2897-2907.
38. Mitri J., Castillo J., Pittas A.G. Diabetes and risk of non-Hodgkin's lymphoma: a meta-analysis of observational studies. Diabetes Care 2008, 31:2391-2397.
39. Castillo J.J., Mull N., Reagan J.L., Nemr S., Mitri J. Increased incidence of non-Hodgkin lymphoma, leukemia, and myeloma in patients with diabetes mellitus type 2: a meta-analysis of observational studies. Blood 2012, 119:4845-4850.
40. Alexander D.D., Mink P.J., Adami H.O., Chang E.T., Cole P., Mandel J.S., et al. The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer 2007, 120(Suppl 12):1-39.
41. Yoffe B., Noonan C.A., Melnick J.L., Hollinger F.B. Hepatitis B virus DNA in mononuclear cells and analysis of cell subsets for the presence of replicative intermediates of viral DNA. J Infect Dis 1986, 153:471-477.
42. Galun E., Ilan Y., Livni N., Ketzinel M., Nahor O., Pizov G., et al. Hepatitis B virus infection associated with hematopoietic tumors. Am J Pathol 1994, 145:1001-1007.
43. Marcucci F., Mele A. Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities. Blood 2011, 117:1792-1798.
44. Talamo T.S., Dekker A., Gurecki J., Singh G. Primary hepatic malignant lymphoma: its occurrence in a patient with chronic active hepatitis, cirrhosis, and hepatocellular carcinoma associated with hepatitis B viral infection. Cancer 1980, 46:336-339.
45. Viswanatha D.S., Dogan A. Hepatitis C virus and lymphoma. J Clin Pathol 2007, 60:1378-1383.
46. Bouvard V., Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F., et al. A review of human carcinogens - part B: biological agents. Lancet Oncol 2009, 10:321-322.
47. Dewantoro O., Gani R.A., Akbar N. Hepatocarcinogenesis in viral hepatitis B infection: the role of HBx and p53. Acta Med Indones 2006, 38:154-159.
48. Leung N. HBV and liver cancer. Med J Malaysia 2005, 60(Suppl B):63-66.
49. Wang X.W., Forrester K., Yeh H., Feitelson M.A., Gu J.R., Harris C.C. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci U S A 1994, 91:2230-2234.
50. Chan C., Wang Y., Chow P.K., Chung A.Y., Ooi L.L., Lee C.G. Altered binding site selection of P53 transcription cassettes by hepatitis B virus X protein. Mol Cell Biol 2012.
51. Brechot C., Thiers V., Kremsdorf D., Nalpas B., Pol S., Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely occult. Hepatology 2001, 34:194-203.